Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors
- 20 November 2001
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 54 (1) , 37-45
- https://doi.org/10.1016/s0166-3542(01)00210-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected AdultsAntimicrobial Agents and Chemotherapy, 2001
- HUMAN RENAL ORGANIC ANION TRANSPORTER 1 (hOAT1) AND ITS ROLE IN THE NEPHROTOXICITY OF ANTIVIRAL NUCLEOTIDE ANALOGSNucleosides, Nucleotides and Nucleic Acids, 2001
- Peripheral neuropathy: zalcitabine reassessedInternational Journal of STD & AIDS, 2000
- Update on highly active antiretroviral therapy: progress and strategiesBiomedicine & Pharmacotherapy, 2000
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapyJournal of Internal Medicine, 1994
- 2',3'-Didehydro-3'-deoxythymidine (d4T) in Patients with AIDS or AIDS-Related Complex: A Phase I TrialThe Journal of Infectious Diseases, 1993
- A semi-automated neutral red based chemosensitivity assay for drug screeningInvestigational New Drugs, 1990
- 3′‐Azido‐3′‐deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cellsBritish Journal of Haematology, 1988